Published in Infect Immun on August 01, 2001
Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun (2006) 2.63
CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques. AIDS Res Hum Retroviruses (2012) 1.02
Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun (2004) 0.93
Identification of M. tuberculosis-specific Th1 cells expressing CD69 generated in vivo in pleural fluid cells from patients with tuberculous pleurisy. PLoS One (2011) 0.83
Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis. Eur J Immunol (2012) 0.81
Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis. Niger Med J (2013) 0.75
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol (1984) 17.76
The isolation and characterization of the human suppressor inducer T cell subset. J Immunol (1985) 6.69
The isolation and characterization of the human helper inducer T cell subset. J Immunol (1985) 5.21
T cell memory. Annu Rev Immunol (1998) 5.20
CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol (1994) 3.50
Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol (1993) 3.01
A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 2.44
Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun (1995) 2.39
The host immune response to tuberculosis. Am J Respir Crit Care Med (1998) 2.35
Biology of the interleukin-2 receptor. Adv Immunol (1998) 2.08
The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest (1994) 2.07
The role of T-cell subsets in Mycobacterium tuberculosis infection. Infect Agents Dis (1996) 1.88
A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol (1997) 1.83
Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med (1996) 1.60
CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol (1999) 1.58
Antigen-induced proliferative response of lavage and blood T lymphocytes. Comparison of cells from normal subjects and patients with sarcoidosis. Am Rev Respir Dis (1991) 1.52
Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J Clin Invest (2000) 1.49
Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med (1998) 1.44
Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol (1992) 1.43
Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med (1990) 1.37
Disease-specific changes in gammadelta T cell repertoire and function in patients with pulmonary tuberculosis. J Immunol (1996) 1.36
Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood (1996) 1.34
Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med (1996) 1.29
Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity. J Immunol (1995) 1.25
Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung. Thorax (1999) 1.17
T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J Infect Dis (1996) 1.16
Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am J Respir Crit Care Med (1994) 1.14
Identification of subsets of human T cells capable of enhanced transendothelial migration. J Immunol (1992) 1.12
Early preferential stimulation of gamma delta T cells by TNF-alpha. J Immunol (1998) 1.05
Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J Infect Dis (1996) 1.05
Most human pulmonary infiltrating lymphocytes display the surface immune phenotype and functional responses of sensitized T cells. Am J Respir Cell Mol Biol (1991) 1.02
CD45RA-expressing memory/effector Th cells committed to production of interferon-gamma lack expression of CD31. Immunol Lett (1997) 1.01
Increased T-cell receptor vbeta8+ T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: a potential role for microbial superantigens. J Allergy Clin Immunol (1999) 0.96
Activation of NF-kappaB in Mycobacterium tuberculosis- induced interleukin-2 receptor expression in mononuclear phagocytes. Am J Respir Crit Care Med (1999) 0.95
T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis. Am J Respir Crit Care Med (1994) 0.95
Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects. Chest (1993) 0.92
Expression of surface antigens distinguishing "naive" and previously activated lymphocytes in bronchoalveolar lavage fluid. Thorax (1990) 0.91
CD29 expression on CD4+ gingival lymphocytes supports migration of activated memory T lymphocytes to diseased periodontal tissue. Oral Microbiol Immunol (1997) 0.90
Characterization of normal human lung lymphocytes and interleukin-2-induced lung T cell lines. Am J Respir Cell Mol Biol (1990) 0.87
Differential expression of VLA-alpha 4 and VLA-beta 1 discriminates multiple subsets of CD4+CD45R0+ "memory" T cells. J Immunol (1992) 0.87
The repertoire of T-lymphocytes recovered by bronchoalveolar lavage from healthy nonsmokers. Eur Respir J (1996) 0.85
Intragraft proliferating T lymphocytes are associated with moderate acute pulmonary rejection. Transplantation (2000) 0.84
Flow cytometric characterisation of the "false naive" (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis. Rheumatol Int (1996) 0.84
Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis. Thorax (1995) 0.83
Human CD4/CD45RA+ and CD4/CD45RA- T cell subsets express CD4-p56lck complexes, CD4-associated lipid kinases, TCR/CD3-p59fyn complexes, and share similar tyrosine kinase substrates. Int Immunol (1993) 0.83
Immunophenotyping of bronchoalveolar lavage lymphocytes. Clin Diagn Lab Immunol (1998) 0.83
Restricted T-cell antigen receptor repertoire in bronchoalveolar T cells from normal humans. Hum Immunol (1996) 0.82
Characterization of local memory cells in stage-classified pulmonary tuberculosis: preliminary observations. Scand J Immunol (1998) 0.79
Specificity of T cells in human resistance to Mycobacterium tuberculosis infection. Cell Immunol (1995) 0.78
Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest (2001) 3.10
Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis. Lancet (1994) 3.04
Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. Mol Cell (1998) 2.90
Enhanced surveillance for pregnancy-associated mortality--Maryland, 1993-1998. JAMA (2001) 2.90
Identification of complexes between the COOH-terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-activating protein. J Biol Chem (1997) 2.69
Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med (1987) 2.62
Acyl-coenzyme A:cholesterol acyltransferase. Annu Rev Biochem (1997) 2.41
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet (1997) 2.40
Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest (1993) 2.38
The host immune response to tuberculosis. Am J Respir Crit Care Med (1998) 2.35
Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA (2001) 2.20
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med (1989) 2.16
Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol (1993) 2.04
Isolation of cholesterol-requiring mutant Chinese hamster ovary cells with defects in cleavage of sterol regulatory element-binding proteins at site 1. J Biol Chem (1998) 1.93
Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol (1997) 1.89
Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am J Respir Crit Care Med (1996) 1.88
Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest (1995) 1.85
Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet (2000) 1.85
Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med (1997) 1.83
Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest (1998) 1.79
Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet (1998) 1.75
Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J Natl Cancer Inst (1995) 1.70
Large pleural effusions occurring after coronary artery bypass grafting. Cardiovascular Surgery Associates, PC. Ann Intern Med (1999) 1.68
Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest (1994) 1.68
Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest (1995) 1.68
Autocatalytic processing of site-1 protease removes propeptide and permits cleavage of sterol regulatory element-binding proteins. J Biol Chem (1999) 1.65
Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax (1996) 1.61
Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med (1996) 1.60
Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Proc Natl Acad Sci U S A (1994) 1.50
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med (1998) 1.44
Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes. Infect Immun (1997) 1.44
Pleural tuberculosis and HIV infection. Chest (1994) 1.42
Coagulopathies in patients after transurethral resection of the prostate: spinal versus general anesthesia. Anesth Analg (1995) 1.40
Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations. Proc Natl Acad Sci U S A (2004) 1.39
Comprehensive tuberculosis control for patients at high risk for noncompliance. Am J Respir Crit Care Med (1995) 1.31
Spontaneous internalization of Class I major histocompatibility complex molecules in T lymphoid cells. J Exp Med (1984) 1.29
Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med (1996) 1.29
Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol Cell Biol (1993) 1.28
Peripheral-blood-based PCR assay to identify patients with active pulmonary tuberculosis. Lancet (1996) 1.27
A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. J Trauma Stress (2000) 1.26
Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum (2006) 1.22
A randomized double-blinded multicenter comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery. Anesth Analg (2001) 1.22
Structure of membrane holes in osmotic and saponin hemolysis. J Cell Biol (1973) 1.21
Isolation of the gene for the beta subunit of RNA polymerase from rifampicin-resistant Mycobacterium tuberculosis and identification of new mutations. Am J Respir Cell Mol Biol (1994) 1.20
Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res (1995) 1.20
Human acyl-CoA:cholesterol acyltransferase-1 in the endoplasmic reticulum contains seven transmembrane domains. J Biol Chem (1999) 1.19
Current approaches to the diagnosis of active pulmonary tuberculosis. Am J Respir Crit Care Med (1994) 1.18
Pneumoconiosis and exposures of dental laboratory technicians. Am J Public Health (1984) 1.18
Differential neuroprotection from human heat shock protein 70 overexpression in in vitro and in vivo models of ischemia and ischemia-like conditions. Exp Neurol (2001) 1.17
Regulation and immunolocalization of acyl-coenzyme A: cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J Biol Chem (1995) 1.17
The significance of Mycobacterium avium complex cultivation in the sputum of patients with pulmonary tuberculosis. Chest (1997) 1.16
Hut lung. A domestically acquired particulate lung disease. Medicine (Baltimore) (2000) 1.13
In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother (1998) 1.12
Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J Infect Dis (1993) 1.12
Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1995) 1.12
Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk. Oncogene (2011) 1.12
Early responses to infection: chemokines as mediators of inflammation. Curr Opin Immunol (1997) 1.11
Effects of lead on the female and reproduction: a review. Mt Sinai J Med (1977) 1.10
Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. Am J Respir Crit Care Med (1998) 1.10
Clinical utility of the polymerase chain reaction in the diagnosis of infections due to Mycobacterium tuberculosis. Chest (1994) 1.09
Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect. Hum Gene Ther (2001) 1.08
Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol (2014) 1.08
Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J Immunol (1997) 1.06
Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells. Infect Immun (1994) 1.05
Prostate stem cells and prostate cancer. Cold Spring Harb Symp Quant Biol (2005) 1.05
Respiratory disease in Utah coal miners. Am Rev Respir Dis (1981) 1.05
Biomarkers of lung inflammation in recreational joggers exposed to ozone. Am J Respir Crit Care Med (1996) 1.05
Transbronchial needle aspiration (TBNA) in patients infected with HIV. Am J Respir Crit Care Med (1998) 1.04
Basophilic stippling of red blood cells: a nonspecific finding of multiple etiology. Am J Ind Med (1984) 1.04
The polymerase chain reaction in the diagnosis and evaluation of pulmonary infections. Am J Respir Crit Care Med (1995) 1.03
Undifferentiated U937 cells transfected with chemoattractant receptors: a model system to investigate chemotactic mechanisms and receptor structure/function relationships. J Leukoc Biol (1997) 1.03
Morphologic characterization of alveolar macrophages from subjects with occupational exposure to inorganic particles. Am Rev Respir Dis (1989) 1.02
The third epidemic--multidrug-resistant tuberculosis. Chest (1994) 1.02
Localization of hepatitis delta virus RNA in the nucleus of human cells. RNA (1998) 1.02
Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res (1993) 1.01
Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression. Gene Ther (2005) 1.01
Increasing incidence of Mycobacterium xenopi at Bellevue hospital: An emerging pathogen or a product of improved laboratory methods? Chest (2000) 0.99
Cloning and sequencing of the structural region and expression of putative core gene of hepatitis C virus from a British case of chronic sporadic hepatitis. J Gen Virol (1992) 0.99
Radiology uses of the Internet. Radiol Manage (1995) 0.99
Health effects among refrigeration repair workers exposed to fluorocarbons. Br J Ind Med (1986) 0.98
Acidification of internalized class I major histocompatibility complex antigen by T lymphoblasts. Cell Immunol (1984) 0.97
Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy. J Clin Invest (1987) 0.97
Asbestos-induced sister chromatid exchanges in cultured Chinese hamster ovarian fibroblast cells. J Environ Pathol Toxicol (1980) 0.97
Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells. Infect Immun (2003) 0.95
A simple technique for fat biopsy of PBB-exposed individuals. Environ Health Perspect (1978) 0.95
Activation of NF-kappaB in Mycobacterium tuberculosis- induced interleukin-2 receptor expression in mononuclear phagocytes. Am J Respir Crit Care Med (1999) 0.95
Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA. J Gen Virol (1994) 0.95
Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch Int Pharmacodyn Ther (1990) 0.94
CD4-T-cell antigen receptor complexes on human leukemia T cells. Proc Natl Acad Sci U S A (1990) 0.94
Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector. Hum Gene Ther (2000) 0.93
Split fractures of the lateral tibial plateau: evaluation of three fixation methods. J Orthop Trauma (1996) 0.93
Mild hypothermia increases Bcl-2 protein expression following global cerebral ischemia. Brain Res Mol Brain Res (2001) 0.92
Review: pneumothorax in patients with AIDS-related Pneumocystis carinii pneumonia. Am J Med Sci (1996) 0.92